Amgen | AMGN - Trade Debtors

Stock Price
343.04
Daily Change
2.86 0.84%
Monthly
-1.71%
Yearly
18.88%
Q2 Forecast
337.18

Amgen reported $9.57B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
ALKERMES USD 334.02M 21.08M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Exelixis USD 286.92M 24.38M Dec/2025
Genmab DKK 1.17B 119M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Takeda JPY 757.92B 55.68B Dec/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025